vimarsana.com
Home
Live Updates
Transcend Nhl 001 - Breaking News
Pages:
Latest Breaking News On - Transcend nhl 001 - Page 1 : vimarsana.com
Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study
Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma.
Switzerland
Lugano
Ticino
Alexey-danilov
Lisocabtagene-maraleucel
International-conference-on-malignant-lymphoma
Primary-analysis-results
Seamless-design
Partnership-with
International-conference
Malignant-lymphoma
Transcend-nhl-001
vimarsana © 2020. All Rights Reserved.